Kimberly Schat
Nurse Practitioner · Chickasha, OKNPI 1194250738
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 28.6% of the total. Reporting peaked in 2023 at $1,167 and has fallen 72.0% since, to $327 in 2025. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$952
- Teva Pharmaceuticals USA, Inc.$579
- Otsuka America Pharmaceutical, Inc.$328
- Johnson & Johnson$319
- Alkermes, Inc.$186
- plus $621 from 10 others
What the payments were for
- Food & beverage$4,183100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 100 | $1,198 |
| AbbVie | 68 | $952 |
| Teva Pharmaceuticals USA, Inc. | 34 | $579 |
| Otsuka America Pharmaceutical, Inc. | 20 | $328 |
| Johnson & Johnson | 21 | $319 |
| Alkermes, Inc. | 9 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $143 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Almatica Pharma LLC | 3 | $52 |
| Lundbeck LLC | 3 | $51 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Merck | 2 | $35 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,183 in reported general payments places this provider in the 90th percentile of 824 nurse practitioner providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Chickasha
- Jenny GuthrieTulsa$106K
- Leah MeltonNorman$87K
- Sara GoreOklahoma City$52K
- Teisha GalleglyMoore$43K
- Stacy NewberryTulsa$28K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Monica LawsonNorman$15K
- Amanda SmallTulsa$14K
- Janelle WagnerOklahoma City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.